Luder, C.
61  Ergebnisse:
?
1

Comparative effectiveness of TNF inhibitors and tocilizumab..:

Lauper, Kim ; Mongin, Denis ; Iannone, Florenzo...
Lauper , K , Mongin , D , Iannone , F , Kristianslund , E K , Kvien , T K , Nordström , D C , Pavelka , K , Pombo-Suarez , M , Rotar , Z , Santos , M J , Codreanu , C , Lukina , G , Gale , S L , John , M , Luder , Y , Courvoisier , D S & Gabay , C 2019 , ' Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis ' , Seminars in arthritis and rheumatism . https://doi.org/10.1016/j.semarthrit.2019.06.020.  , 2019
 
?
2

Comparative effectiveness of tocilizumab versus TNF inhibit..:

Lauper, Kim ; Nordström, Dan C ; Pavelka, Karel...
Lauper , K , Nordström , D C , Pavelka , K , Hernández , M V , Kvien , T K , Kristianslund , E K , Santos , M J , Rotar , Ž , Iannone , F , Codreanu , C , Lukina , G , Gale , S L , Sarsour , K , Luder , Y , Courvoisier , D S & Gabay , C 2018 , ' Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: Analyses from the pan-European TOCERRA register collaboration ' , Annals of the rheumatic diseases , vol. 77 , no. 9 , pp. 1276-1282 . https://doi.org/10.1136/annrheumdis-2017-212845.  , 2018
 
?
3

Apoptotic markers in protozoan parasites:

Jiménez-Ruiz, A ; Alzate, J.F ; Macleod, E.T...
info:eu-repo/semantics/altIdentifier/doi/10.1186/1756-3305-3-104.  , 2010
 
?
4

The diverse expression of immunity in humans at distinct st..:

Soboslay, P T ; Geiger, S M ; Weiss, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456700.  , 1997
 
?
 
?
7

To sleep or not to sleep, that is the question: A systemati..:

Schäfer, Sarah K ; Lüder, Charina C ; Porcheret, Kate...
https://ars.els-cdn.com/content/image/1-s2.0-S0005796723001080-mmc1.pdf.  , 2023
 
?
 
?
11

Down-regulation of MHC class II molecules and inability to ..:

Lüder, C G K ; Lang, T ; Beuerle, B.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904980.  , 1998
 
?
 
?
 
?
15

Functional ability and quality of life in critical illness ..:

Eggmann, Sabrina ; Luder, Gere ; Verra, Martin L...
Eggmann , S , Luder , G , Verra , M L , Irincheeva , I , Bastiaenen , C H G & Jakob , S M 2020 , ' Functional ability and quality of life in critical illness survivors with intensive care unit acquired weakness : A secondary analysis of a randomised controlled trial ' , PLOS ONE , vol. 15 , no. 3 , 0229725 . https://doi.org/10.1371/journal.pone.0229725.  , 2020
 
1-15